Company

Patent
Patents related
to liver cancer
diagnosis technology
  • 1. Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene
    - South Korea: 10-2052089
    - South Korea: 10-2103886
    - South Korea: 10-2103887
    - PCT: PCT/KR2018/014207
    - USA: US16/766504
    - USA: US17/728240
    - Europe: EP18881098
    - China: CN201880075735
    - Japan: 7306723(JP2020-546257)
    - Japan: JP2022-129672
    - Singapore: 11202203494U
    - Singapore: 11202203494U
  • 2. Dna methylation marker for predicting recurrence of liver cancer, and use thereof
    - South Korea: 10-2068310
    - PCT: PCT/KR2020/002727
    - USA: US17/434675
    - Europe: EP20762970.0
    - China: CN202080017304.2
    - Japan: 7340879(JP2021-550256)
    - Singapore: SG11202109382S
  • 3. Method for determining if origin of biological sample is from liver tissue
    - South Korea: 10-2103885
    - PCT: PCT/KR2020/013290
    - Singapore: 11202203494U
    - USA: 17/766,301
    - Europe: 20873439.2
    - China: 202080084761.3
    - Japan: 2022-521197
  • 4. Method for determining whether biological sample has originated from liver cancer tissue
    - South Korea: 10-215044
    - PCT: PCT/KR2020/013288
    - Singapore: SG 11202203577S
    - USA: 17/714,271
    - Europe: 20874860.8
    - China: 202080084767
    - Japan: 2022-521203
  • 5. Development of methylation rate measurement technologies and algorithms for methylation markers predicting liver cancer prognosis
    - South Korea: 10-2021-0161420
  • 6. Method to detect methylation and compositions thereof
    - South Korea: 10-2022-0051452
    - PCT: PCT/KR2023/004710
  • 7. Method to detect compositions for identifying methylation of nucleic acid, and whether nucleic acid is methylated
    - South Korea: 10-2022-0051454
    - PCT: PCT/KR2023/004709
    - Taiwan: 112113288
  • 8. Formulation for Predicting the Risk of Liver Cancer Development
    - South Korea: 10-2023-0010403
  • 9. Methods for Prognostic Prediction of Liver Cancer
    - South Korea: 10-2021-0161420
Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene
Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene
Dna methylation marker for predicting recurrence of liver cancer, and use thereof
Method for identifying whether biological sample is derived from liver tissue
Method for assessing prognosis or risk stratification of liver cancer by using cpg methylation variation in gene
Method for determining whether biological sample has originated from liver cancer tissue
Certificate of Inno-Biz
Certificate of Clinical Test GMP